Cell penetrating elastin-like polypeptides for therapeutic peptide delivery
- 15 May 2010
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 62 (15), 1486-1496
- https://doi.org/10.1016/j.addr.2010.05.003
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injectionNature Materials, 2009
- Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrierInternational Journal of Cancer, 2009
- Application of Thermally Responsive Elastin-like Polypeptide Fused to a Lactoferrin-derived Peptide for Treatment of Pancreatic CancerMolecules, 2009
- Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeuticsBritish Journal of Pharmacology, 2009
- Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonistJournal of Controlled Release, 2008
- A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistanceInvestigational New Drugs, 2007
- Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude miceJournal of Controlled Release, 2006
- Trojan peptides: the penetratin system for intracellular deliveryTrends in Cell Biology, 1998
- Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21Published by Elsevier ,1995
- A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigenCurrent Biology, 1995